Symptom Tracking in Long COVID Patients Using Formula C™ Sublingual Drops

Completed

Conditions studied: Long COVID, Long Covid19, Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Long Haul COVID, Long-Haul COVID-19

In brief

This is a digital symptom tracking study of Formula C™, a full cannabis flower formulation, rich in cannabinoids and terpenes, that has been shown to improve symptoms in people with Long COVID. Participants 21 and older will take Formula C™ for 90 days. During that time, participants will answer weekly surveys to track symptoms and wellbeing.

Key facts

Study ID

NCT06163690

Run by

Endourage, LLC

People needed

20

Starts

2023-12-13

Expected to finish

2025-01-31

Last updated by the study team

2025-02-25

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be at least 21 years of age.
• Willing and able to read, understand, and sign the informed consent.
• Willing to comply with all study procedures.
• Must have device to access the internet to complete surveys online.
• A diagnosis of Long COVID from a health care provider.

You may not qualify if…

• Non-English speaking, as the surveys are developed in the English language.
• Known allergies to hemp seeds or hemp-derived products, medical cannabis, coconut oil.
• Pregnancy, or planning to become pregnant in the next 3 months

Where it is running

• Endourage, LLC — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.